Your browser doesn't support javascript.
loading
Ruthenium-Mediated 18F-Fluorination and Preclinical Evaluation of a New CB1 Receptor Imaging Agent [18F]FPATPP.
Lahdenpohja, Salla; Rajala, Noora A; Helin, Jatta S; Haaparanta-Solin, Merja; Solin, Olof; López-Picón, Francisco R; Kirjavainen, Anna K.
Affiliation
  • Lahdenpohja S; Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland.
  • Rajala NA; Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland.
  • Helin JS; Preclinical Imaging, Turku PET Centre, University of Turku, Turku, Finland.
  • Haaparanta-Solin M; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Solin O; Preclinical Imaging, Turku PET Centre, University of Turku, Turku, Finland.
  • López-Picón FR; MediCity Research Laboratory, University of Turku, Turku, Finland.
  • Kirjavainen AK; Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Turku, Finland.
ACS Chem Neurosci ; 11(13): 2009-2018, 2020 07 01.
Article in En | MEDLINE | ID: mdl-32479723
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ruthenium / Fluorine Radioisotopes Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2020 Document type: Article Affiliation country: Finland Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ruthenium / Fluorine Radioisotopes Limits: Animals Language: En Journal: ACS Chem Neurosci Year: 2020 Document type: Article Affiliation country: Finland Country of publication: United States